CARULLI, Lucia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.134
AS - Asia 6.886
EU - Europa 5.900
SA - Sud America 877
Continente sconosciuto - Info sul continente non disponibili 194
AF - Africa 147
OC - Oceania 21
Totale 30.159
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.857
SG - Singapore 2.330
CN - Cina 1.724
GB - Regno Unito 1.568
IT - Italia 1.183
HK - Hong Kong 848
BR - Brasile 661
DE - Germania 633
VN - Vietnam 625
SE - Svezia 493
FI - Finlandia 388
PL - Polonia 370
UA - Ucraina 341
BD - Bangladesh 320
FR - Francia 259
TR - Turchia 249
RU - Federazione Russa 246
KR - Corea 141
IN - India 137
CA - Canada 136
BG - Bulgaria 114
ID - Indonesia 77
IQ - Iraq 73
AR - Argentina 72
MX - Messico 61
JP - Giappone 59
NL - Olanda 46
PK - Pakistan 44
AE - Emirati Arabi Uniti 39
IE - Irlanda 38
ES - Italia 34
BE - Belgio 33
ZA - Sudafrica 31
EC - Ecuador 30
MA - Marocco 29
TW - Taiwan 29
AT - Austria 28
VE - Venezuela 27
CO - Colombia 26
MY - Malesia 24
PH - Filippine 22
CL - Cile 21
SA - Arabia Saudita 21
CR - Costa Rica 20
UZ - Uzbekistan 18
CZ - Repubblica Ceca 17
KE - Kenya 17
IR - Iran 16
AU - Australia 15
CH - Svizzera 15
DZ - Algeria 14
PY - Paraguay 14
EG - Egitto 12
ET - Etiopia 12
JO - Giordania 12
LT - Lituania 11
RO - Romania 11
TT - Trinidad e Tobago 11
JM - Giamaica 10
NO - Norvegia 10
PE - Perù 10
AZ - Azerbaigian 9
BO - Bolivia 9
NP - Nepal 9
OM - Oman 9
AL - Albania 8
PA - Panama 8
TH - Thailandia 7
BY - Bielorussia 6
DK - Danimarca 6
KG - Kirghizistan 6
NI - Nicaragua 6
SI - Slovenia 6
TN - Tunisia 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
EU - Europa 5
GE - Georgia 5
HN - Honduras 5
HU - Ungheria 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
RS - Serbia 5
DO - Repubblica Dominicana 4
GR - Grecia 4
IL - Israele 4
PS - Palestinian Territory 4
PT - Portogallo 4
SC - Seychelles 4
SV - El Salvador 4
UG - Uganda 4
AM - Armenia 3
BF - Burkina Faso 3
GT - Guatemala 3
HR - Croazia 3
KZ - Kazakistan 3
MD - Moldavia 3
PR - Porto Rico 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 29.931
Salva come PNG Salva come JPEG
Città #
Singapore 1.599
Ashburn 1.421
Fairfield 1.379
Santa Clara 1.306
Southend 978
Hong Kong 836
Woodbridge 759
Houston 735
San Jose 701
Chandler 697
Jacksonville 551
Chicago 537
Seattle 473
Wilmington 468
Cambridge 466
Dearborn 417
Ann Arbor 408
Los Angeles 406
Hefei 355
Warsaw 354
Beijing 343
Council Bluffs 343
Nyköping 319
London 287
Helsinki 266
Modena 232
Salt Lake City 211
Ho Chi Minh City 189
New York 179
The Dalles 167
San Diego 156
Hanoi 154
Izmir 134
Munich 130
Seoul 129
Princeton 122
Tampa 114
Sofia 111
Milan 102
Eugene 101
Shanghai 98
Elk Grove Village 90
Buffalo 89
Lauterbourg 88
Columbus 78
Dallas 78
Boardman 59
São Paulo 59
Rome 58
Fremont 54
Sterling 54
Moscow 52
Des Moines 49
Lancaster 49
Jakarta 46
Phoenix 45
Bologna 44
Guangzhou 40
Baghdad 39
Frankfurt am Main 38
Redwood City 38
Orem 36
Tokyo 36
Toronto 33
Turku 33
Dublin 32
Mexico City 31
Brooklyn 30
Broomfield 30
Detroit 30
Brussels 29
Montreal 28
Dulles 27
Miami 27
Falls Church 26
San Francisco 26
Bremen 25
Haiphong 24
Da Nang 23
Kunming 23
Chennai 22
San Mateo 22
Dongguan 20
Naples 20
Parma 20
Atlanta 19
Manchester 19
Zhengzhou 18
Amsterdam 17
Bari 17
Dhaka 17
Hounslow 17
Norwalk 17
Nuremberg 17
Tashkent 17
Kansas City 16
Denver 15
Mumbai 15
Philadelphia 15
Rio de Janeiro 15
Totale 20.784
Salva come PNG Salva come JPEG
Nome #
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 726
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 473
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 462
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 457
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 444
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 435
Gender, fatty liver and GGT 423
Review article: diabetes, genetics and ethnicity 421
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 414
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 414
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 408
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 400
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 392
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 388
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 386
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 381
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 380
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 376
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 375
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 370
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 368
Hepatic steatosis and insulin resistance: Does etiology make a difference? 363
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 362
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 350
Telomere length elongation after weight loss intervention in obese adults 349
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 348
Endocrine and liver interaction: the role of endocrine pathways in NASH 344
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 342
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 335
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 333
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 331
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 328
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 325
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 315
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 314
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 311
Review article: effect of bile salt pool composition on hepatic and biliary functions 308
Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomeres involvement on line pubblication 03-Oct-2012Hepatology- 305
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 305
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 299
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 287
The Individual Care Plan (ICP): proposal of a model to improve the communication between hospital and primary health care services 287
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 286
Telomere and telomerase in chronic liver disease and hepatocarcinoma 286
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 285
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 284
Olanzapine metabolic side effects: a weight gain issue? 284
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 275
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 275
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 273
Antiretroviral drugs induced metabolic diseases in HIV infected patients. 269
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 268
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 260
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 250
Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. 247
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 246
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 243
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 243
Bleeding jejunal varices and portal thrombosis in a splenectomized patient with hereditary spherocytosis 240
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 238
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 235
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 233
Regolazione della sintesi di colesterolo e acidi biliari 229
Telomere shortening as genetic risk factor of liver cirrhosis 228
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 226
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 224
Fatty liver, carotid disease and gallstones: A study ofage-related associations 219
Gender differences in chronic alcoholic and viral liver diseases 218
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 217
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 216
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 213
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 213
Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption 212
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 211
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 211
Increase degradation of cholesterol via the alternate pathway of bile acid biosynthesis in primary hypercholesterolemia. 210
Telomeres and atherosclerosis 209
Cirrosi criptogenetiche. Un report di 5 pazienti 208
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 207
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 203
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 202
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 200
Reply 199
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 195
The genetic basis of Insulin resistance. A brief review 193
Cholestatic icterus: is there still a role for the clinic? 193
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 188
Risk for cardiovascular events in a local population of diabetic patients 184
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 179
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 178
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 172
Fatty liver disease associated with epatiti C and/or human immunodeficiency virus: characterization of the link between hepatic steatosis, insulin resistance and metabolic syndrome. 167
DIABETES AND CARDIOVASCULAR EVENTS: USEFULNESS AND LIMITS OF RISK FUNCTIONS 167
regulation of bile acid synthesis in humans: availability of newly sythetized cholesterol is a limiting fator during pharmacological inhibition of bile acid recirculation. 165
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 164
La calcolosi biliare. 164
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 164
Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma 161
Invecchiamento ed alterazioni dell’omeostasi del colesterolo: studi dei livelli plasmatici degli steroli idrossilati come markers metabolici. 159
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 159
Totale 28.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.987 0 0 160 203 64 115 182 147 282 133 421 280
2022/20231.970 220 203 170 197 211 312 42 173 248 15 78 101
2023/20241.332 55 71 86 91 253 134 209 165 26 31 65 146
2024/20254.606 120 56 87 322 944 705 304 236 431 213 489 699
2025/202610.494 470 305 606 1.317 2.613 1.022 1.086 404 837 787 583 464
2026/2027990 264 554 172 0 0 0 0 0 0 0 0 0
Totale 30.159